drug

elironrasib

Phase 2updated 5mo ago

by $RVMD Revolution Medicines, Inc.

Phase 2

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying elironrasib

phase2Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumorsrecruitingn=534
phase2Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumorsrecruitingn=370

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

elironrasib

Phase 2updated 5mo ago

by $RVMD Revolution Medicines, Inc.

Phase 2

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying elironrasib

phase2Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumorsrecruitingn=534
phase2Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumorsrecruitingn=370

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

elironrasib

indications

all catalysts(0)

Trials studying elironrasib

News(0)

Report a data issue

comments(0)

elironrasib

indications

all catalysts(0)

Trials studying elironrasib

News(0)

Report a data issue

comments(0)